Tom Beer, M.D.

Tom Beer, M.D.

Speaking

Upcoming Events:



Recent Speaking Engagements:


2022

PRIME CME webcast Navigating the Latest Evidence on Multi-Cancer Early Detection Technologies, July 2022

Real World Data and Practical Considerations in the Use of Novel Hormonal Agents in CRPC. How Guidelines and Clinical Trial Data Inform the Modern Day Treatment of Advanced Prostate Cancer, PER Satellite Symposium at ASCO, June 4, 2022, Chicago, IL

How to Follow-Up Patients Who Had PSMA PET as Baseline Imaging. APCCC, April 30 2022, Basel, Switzerland

Multi-Cancer Early Detection Tests: Raising Awareness of Novel Cancer Control Strategies in Primary Care. April 2022

Pathfinder Study, Bay Area Hospital’s Clinical Advisory Group, February 2022, Coos Bay OR

Emerging Multi-Cancer Early Detection Strategies, OHSU OBGYN Grand Rounds, March 2022, Portland OR

Multi-Cancer Early Detection in 2022, 6th Annual Knight Cancer Network Symposium, March 2022, Portland OR

2021

Emerging Multi-Cancer Early Strategies, OHSU Hematology & Medical Oncology Grand Rounds, August 2021, Portland, OR

Emerging Multi-Cancer Early Strategies, OHSU Department of Medicine Grand Rounds, August 2021, Portland OR

Prostate Cancer, C616 Advanced Topics in Cancer Biology, May 2021, Portland, OR

Latest Developments in Blood-Based Multi-Cancer Detection Tests:  Closer Than You Think…, OHSU Cancer Institute Lunch & Learn Series, February 2021, Portland OR

Tackling Testosterone to Vanquish Prostate Cancer, 52nd Annual Primary Care Review, February 2021, Portland OR

PARP Inhibitors in Metastatic CRPC, Chinese Health Professionals Development Alliance (HPDA), January 2021

2020

Prostate Cancer and Making Sense of nm-CRPC Treatment Options, Patient Power, Your Prostate Cancer Questions Answered Series, October 28, 2020

Altering the Course of Cancer in Primary Care: Early Detection for Better Long-Term Outcomes, Satellite Symposium at the AAFP Family Medicine Experience (FMX) conference, October 15, 2020

Evolving Landscape of the Prostate Cancer Care Continuum
Challenging Cases in mHSPC
III Astellas Oncology Forum, October 14, 2020

Current Management of Metastatic Castration Resistant Prostate Cancer,
Pacific Northwest Prostate Cancer Conference, September 26, 2020.

Advanced Prostate Cancer: Putting Survival into Perspective, ASCO Virtual Annual Meeting, May 29, 2020

Prostate Cancer, C 616 Advanced Topics in Cancer Biology, May 27, 2020

Pathfinder: A Prospective Trial of a Multi-Cancer Early Detection Test, CEDAR Scientific Advisory Board, May 11, 2020, Portland, OR

Tackling Testosterone to Vanquish Prostate Cancer, OHSU Department of Medicine Grand Rounds, April 14, 2020, Portland, OR


Development of Enzalutamide, OHSU Hematology and Medical Oncology Grand Rounds, March 6, 2020, Portland, OR

Equipping Patients for Care, ZERO Summit, February 24, 2020, Washington DC

Cancer 101: Where we are in 2020, Knight School – January 2020, Knight Cancer Institute, January 21, 2020, Portland, OR

2019

Prostate Cancer Research, Lake Oswego Rotary Club - January 14, 2019, Lake Oswego, OR

Castration Resistant Metastatic Prostate Cancer, National Military Hospital, January 18, 2019, Bogota, Colombia

Castration Resistant Metastatic Prostate Cancer, Sociedad Colombiana de Urologia, January 19, 2019, Cartagena, Colombia

Precision therapy for prostate cancer, at the ZERO Summit, February 25, 2019, Washington DC

Advancing the Care for Non-metastatic CRPC, Regional Summit on Genitourinary Malignancies, April 13, 2019, Pasadena, CA

Terapia personalizada y secuenciación en el tratamiento de la enfermedad metastásica de cáncer de próstata resistente a la terapia de deprivación androgénica (Personalized Therapy and Sequencing in the Treatment of CRPC)


Updates in prostate cancer, 7th International Conference on Advances in Hematology and Oncology, June 29-30, 2019, Seattle, WA

2019 Breaking News On Prostate Cancer: From Chemo, Genetic Testing, Immune or Injection Therapy, Pills, and Beyond, PCRI Conference, September 6-8, 2019, Los Angeles, CA

Prostate Cancer Updates in a Nutshell
Prostate Cancer Clinical Practice Update
October 1, 2019, Cairo, Egypt

Personalized Treatment of Prostate Cancer
Challenges in the Management of mCRPC from the Oncologist's Perspective
Challenges in the Management of mCRPC from the Urologist's Perspective
October 3, 2019, Cairo, Egypt

Congresses' Highlights: Latest Updates in mCRPC
Sequencing Therapy in Prostate Cancer from the Oncologist's Perspective
Sequencing Therapy in Prostate Cancer from the Urologist's Perspective
October 4, 2019, Jeddah, Saudi Arabia

Patient Centric Treatment in mCRPC from the Oncologist's Perspective
Patient Centric Treatment in mCRPC from the Urologist's Perspective
October 5, 2019, Beirut, Lebanon

2018

Prostate Cancer treatment paradigm: Focus on castration resistant prostate cancer (mCRPC), International lecture series, January, Riyadh, Saudi Arabia

Treatment sequencing in advanced prostate cancer: Newly diagnosed and castration resistant metastatic prostate cancer, International lecture series, January, Riyadh, Saudi Arabia

Collaboration between physicians and pharmacists in the management of prostate cancer, International lecture series, January, Riyadh, Saudi Arabia

Optimizing care for patients with advanced prostate cancer, International lecture series, January, Riyadh, Saudi Arabia

Role of novel AR agents in treating mCRPC patients, International lecture series January, Riyadh, Saudi Arabia
Clinical considerations in mCRPC management, International lecture series, January, Jeddah, Saudi Arabia

mCRPC clinical case studies, International lecture series, January, Jeddah, Saudi Arabia

AR targeting in advanced prostate cancer, International lecture series, January, Jeddah, Saudi Arabia

Newly Diagnosed metastatic prostate cancer: Clinical case studies, International lecture series, January, Jeddah, Saudi Arabia

Evolving Standards of Care in Metastatic Prostate Cancer, PRCA Grand Rounds lecture series, January, Rockville, MD

Prostate cancer screening, 48th Annual Primary Care Review, February, Portland, OR

Hepatic effects assessed by review of safety data in enzalutamide castration-resistant prostate cancer (CRPC) trials, Genitourinary Cancers Symposium, February, San Francisco, CA

Looking to the future & Ask the experts, Hormonal therapy in prostate cancer: Improving clinical outcomes in metastatic and non-metastatic disease – prIME Oncology Symposium, February, San Francisco, CA

Changing landscape of CRPC and changing landscape of HSmPC, Enzalutamide Scientific Advisory Board Meeting, March, Dallas, TX

Evolving Standards of Care in Metastatic Prostate Cancer, PRCA Grand Rounds lecture series, March, Long Beach, CA

Big ideas inspire big philanthropy – and lead to big results, 33rd American Council on Gift Annuities conference, April, Seattle, WA

Clinical considerations in mCRPC management, OHSU Hematology & Medical Oncology Grand Rounds, May, Portland, OR

Evolving Standards of Care in Metastatic Prostate Cancer, PRCA Grand Rounds lecture series, May, Bend, OR

AR Targeting in Advanced Prostate Cancer, PeerView’s Symposium: Newest Advances and Strategies in Prostate Cancer, June, Chicago, IL

Evolving Standards of Care in Metastatic Prostate Cancer, PRCA Grand Rounds lecture series, June, Chicago, IL

Prostate Cancer 101, OHSU Knight Prostate Cancer Research Program’s clinical brown bag series, June, Portland, OR

Advancing the care for non-metastatic CRPC, Genitourinary Malignancies Regional Summit Series, July 28th, 2018, Pasadena, CA

The latest in prostate cancer, OHSU Knight Prostate Cancer Support Group, September 4th, 2018, Portland, OR

Current Management of Castration-resistant Prostate Cancer, 18th Annual Pacific NW Prostate Cancer Conference, September 22nd, 2018, Portland, OR/Seattle, WA/Vancouver, BC, Canada

Recent progress in advanced prostate cancer, Columbia Memorial Hospital, September 24th, 2018, Astoria, OR

Novel Approaches to Prostate Cancer Management, October 11th, 2018, Cairo, Egypt

Challenges in Metastatic Castration Resistant Prostate Cancer, October 11th, 2018, Cairo, Egypt

Prostate Cancer Master Class:
Prostate Cancer Management Updates in a Nutshell
Non Metastatic Castration Resistant Prostate Cancer
Sequencing the Options in Prostate Cancer
Multidisciplinary Care Paradigm
October 13th, 2018, Beirut, Lebanon

How to treat mCRPC patients in a rapidly evolving landscape, October 15th, 2018, Alain, United Arab Emirates

How to treat mCRPC patients in a rapidly evolving landscape, October 15th, 2018, Abu Dhabi, United Arab Emirates

How to treat mCRPC patients in a rapidly evolving landscape, October 16th, 2018, Dubai, United Arab Emirates

Food and prostate cancer, The 56th Annual Meeting of Japan Society of Clinical Oncology, October 18, 2018, Yokohama, Japan

Translating clinical ideas into products, Society of Physician Entrepreneurs, November 15, 2018

The era of personalized therapy for GU tumors, at the Genitourinary Malignancies Global Summit Series, November 2018, Banff, Alberta, Canada

2017

Advanced Prostate Cancer: Searching for Optimal Therapy Sequence and Assessing Emerging Treatment Options, OHSU Hematology & Medical Oncology Grand Rounds, February, Portland, OR

AR-V7 – Ready for use in daily clinical decision making?, Advanced Prostate Cancer Consensus Conference (APCCC), March, St. Gallen, Switzerland

Advanced Prostate Cancer Searching for Optimal Therapy Sequence and Assessing Emerging Treatment Options, Creative Educational Concepts Grand Round Series, April, Chicago, IL

Precision Therapy for Metastatic Castration Resistant Prostate Cancer (mCRPC): the Impact of Molecular Discoveries, 105th Japanese Urological Association annual meeting, April, Kagoshima, Japan

Global trend and controversy in CRPC through APCCC, Expert meeting during 105th Japanese Urological Association annual meeting, April, Kagoshima, Japan

Global consensus of advanced prostate cancer, Satellite Symposium in conjunction with the 105th Japanese Urological Association annual meeting, April, Kagoshima, Japan

Recent Developments in Castration Resistant Prostate Cancer (mCRPC), OHSU Knight Prostate Cancer Research Program’s clinical brown bag series, May, Portland, OR

Recent Developments in Castration Resistant Prostate Cancer (mCRPC), OHSU Hematology & Medical Oncology Grand Rounds, May, Portland, OR

Clinical Considerations for a Patient with Hormone-Sensitive, Metastatic Prostate Cancer, PER Medical Crossfire: Personalized Sequencing in Castration-Resistant Prostate Cancer Symposia, June, Chicago, IL

State of the art in prostate cancer treatment, OHSU Knight Prostate Cancer Support Group, September, Portland, OR

Current & Emerging Treatment Options for Advanced Prostate Cancer, Strategies for Managing Symptoms and Treatment Side Effects, and Tools for Living Well with Prostate Cancer, Patient Power Advanced Prostate Cancer Virtual Town Meeting, October, Seattle, WA and live global online audience

Prostate Cancer, OHSU Knight Prostate Cancer Research Program’s clinical brown bag series, November, Portland, OR

Evolving Standards of Care in Metastatic Prostate Cancer, PRCA Grand Rounds lecture series, November, Seattle, WA

Newly Diagnosed Metastatic Disease, Omniprex Prostate Cancer Symposium, November, Portland, OR

Castration-resistant disease: Personalizing therapy and treatment sequencing, Omniprex Prostate Cancer Symposium, December, Portland, OR